2011
Potential therapeutic target discovery by 2D-DIGE proteomic analysis in mouse models of asthma,
F. Quesada Calvo*, M. Fillet*, J. Renaut, C. Crahay, M. Gueders, J. Hacha, G. Paulissen, JM. Foidart, A. Noel, N. Rocks, P. Leprince, D. Cataldo.
*equally contribute to the work
J. Proteome Res. 10(9) (2011) 4291-4301. FI=5,460.
Pre-study and in-study validation of a SPE-LC-MS-MS method for the determination of 5-S-cysteinyldopa, a melamona biomarker, in human plasma,
G. Martin, F. Mansion, V. Houbart, Ph. Paquet, A. Rorive, P. Chiap, J. Crommen, AC. Servais, M. Fillet,
Talanta, 84 (2011) 280-286. FI=3,722.
Optimization of micro-HPLC peak focusing for the detection and quantification of low hepcidin concentrations,
F. Mansion, P. Chiap, V. Houbart, J. Crommen, AC. Servais, and M. Fillet
J. Sep. Sci., 34 (2011) 1820-1827. FI=2,631.
Combination of capillary electrophoresis, molecular modelling and nuclear magnetic resonance to study the interaction mechanisms between single-isomer anionic cyclodextrin derivatives and basic drug enantiomers in a methanolic background electrolyte,
AC. Servais, A. Rousseau, G. Dive, M. Fréderich, J. Crommen, M. Fillet,
J. Chrom. A, 1232 (2012) 59-64. FI=4,194.
Development of a nano liquid chromatography on chip tandem mass spectrometry method for high-sensitivity hepcidin quantitation,
V. Houbart, G. Cobraiville, F. Lecomte, B. Debrus, Ph. Hubert, M. Fillet,
J. Chrom. A, 1218 (2011) 9046-9054. FI=4,194.
Generic systems for the enantioseparation of basic drugs in NACE using single-isomer anionic CDs.
Rousseau A, Gillotin F, Chiap P, Bodoki E, Crommen J, Fillet M, Servais AC.
J. Pharm. Biomed. Anal. 54(1) (2011) 154-159. FI=2,733.
Development and validation of a LC method for the enantiomeric purity determination of S-ropivacaine in a pharmaceutical formulation using a recently commercialized cellulose-based chiral stationary phase and polar non-aqueous mobile phase,
K.S.S. Dossou, P. Chiap, AC. Servais, M. Fillet, J. Crommen,
J. Pharm. Biomed. Anal. 54 (2011) 687-693. FI=2,733.
Improved gel electrophoresis matrix for hydrophobic protein, separation and identification,
C. Tokarski, M. Fillet, Ch. Rolando
Analytical Biochemistry 410 (2011)98-109. FI= 3,236.
Evaluation of chlorine containing cellulose-based chiral stationary phases for the LC enantioseparation of basic pharmaceuticals using polar non-aqueous mobile phases
K.S.S. Dossou, P. Chiap, AC. Servais, M. Fillet, J. Crommen,
Journal of Separation Science, 34(6) (2011) 617-622. FI= 2,631.
Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis.
de Seny D*, Sharif M*, Fillet M, Cobraiville G, Meuwis MA, Marée R, Hauzeur JP, Wehenkel L, Louis E, Merville MP, Kirwan J, Ribbens C, Malaise M.
Ann Rheum Dis. 70(6) (2011) 1144-1152. FI=9,082.
Determination of enantiomeric purity of S-amlodipine by chiral LC with emphasis on reversal of enantiomer elution order.
KS. Dossou, PA. Edorh, P. Chiap, B. Chankvetadze, A-C. Servais, M. Fillet, J. Crommen,
Journal of Separation Science, 34 (2011) 1772-1780. FI=2,631.
Hydroxylated Analogs of ATP-Sensitive Potassium Channel Openers Belonging to 6- and/or 7-Substituted 3-Isopropylamino-4H-1,2,4-benzothiadiazine 1,1-Dioxides: Toward an Improvement of Sulfonylurea Receptor 1 Selectivity and Metabolism Stability.
De Tullio P, Servais AC, Fillet M, Gillotin F, Somers F, Chiap P, Lebrun P, Pirotte B.
J. Med. Chem. 54 (2011) 8353-8361. FI=5,207.
Detection of counterfeit Viagra® by Raman microspectroscopy imaging and multivariate analysis.
Sacré PY, Deconinck E, Saerens L, De Beer T, Courselle P, Vancauwenberghe R, Chiap P, Crommen J and De Beer JO.
J. Pharm. Biomed. Anal. 56(2) (2011) 454-61. FI = 2,979.
Impurity fingerprints for the identification of counterfeit medicines–a feasibility study.
Sacré PY, Deconinck E, Daszykowski M, Courselle P, Vancauwenberghe R, Chiap P, Crommen J and De Beer JO.
Anal.Chim. Acta. 701(2) (2011) 224-31. FI = 4,513.
Development and validation of a ultra-high-performance liquid chromatography-UV method for the detection and quantification of erectile dysfunction drugs and some of their analogues found in counterfeit medicines.
Sacré PY, Deconinck E, Chiap P, Crommen J, Mansion F, Rozet E, Courselle P and De Beer JO.
J. Chromatogr. A, 1218(37) (2011) 6439-47. FI = 4,194.